New Covid-19 variant EG.5 is on the rise in the US. The variant is causing about 17 per cent of the new Covid-19 cases in the country compared to 16 per cent for the next most common lineage, XBB.1.16, according to the latest estimates from the US Centers for Disease Control and Prevention,
The mRNA-based booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
Following the emergence of the highly contagious Delta and Omicron COVID-19 variants, pregnancy-related mortality rates in the United States increased faster in 2021 than the previous year, according to a new study (UMD).
According to Dr Rajeev Jayadevan, Co-chairman of the National IMA Covid task force, XBB.1.5 is an upgraded version of XBB, a recombinant sub-lineage of Omicron that was found a few months ago in multiple countries like Singapore and later in India.
A study in California prisons found recent vaccination and boosters reduce infectiousness, but Infection risk remains high. Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis b
As there have been reports of a surge in COVID cases in some countries, the operational readiness of health facilities is being reviewed in all States and Union Territories in case of another wave.
In the last six months, India reported four cases of the BF.7 Omicron sub-variant, which is driving the current surge of infections in China. Sources said there are currently 10 different variants of Covid-19 in the country, with the latest being BF.7.
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed "Omicron" spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal Science by researchers from Charite - Univers
Washington [US], October 19 (ANI): Researchers analyzed the structures of the receptor-binding domain (RBD) of the SARS-CoV-2 omicron variant and its receptor, angiotensin-converting enzyme 2 (ACE2), to gain insight into the variant's potential animal reservoir.
New Delhi [India], October 18 (ANI): A meeting of Union Health Minister Mansukh Mandaviya with the senior health officials regarding the emergence of Omicron's new sub-variants concluded with the decision to continue masks and COVID19-appropriate behaviour across the country, official sou
New Delhi [India], October 17 (ANI): The Indian SARS-CoV-2 Consortium on Genomics (INSACOG) is likely to issue a bulletin regarding Omicron's new sub-variants BA.5.1.7 and BF.7 reported in India.
New Delhi [India], August 12 (ANI): Amid rising COVID cases in the national capital and other States, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) will review the data of genomic surveillance of COVID-19 variants on Friday, said sources.